Inactive Instrument
Abliva AB Share Price
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 10/01/2014 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/2023 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 06/11/2017 | |
| Director/Board Member | 66 | 27/04/2017 | |
David Bejker
BRD | Director/Board Member | 51 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/03/25 | Sell | Founder | 5,74,978 | 0.0357% | ||
| 07/03/25 | Sell | Founder | 5,74,978 | 0.0357% | ||
| 12/02/25 | Sell | Chief Technology Officer | 31,04,000 | 0.1926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 7.6Cr | |
| +2.24% | +5.83% | +58.47% | +65.65% | 6.67TCr | |
| +4.66% | +5.77% | +16.93% | +82.87% | 5.69TCr | |
| -0.60% | +2.36% | +24.32% | +97.19% | 5.65TCr | |
| +2.55% | +12.69% | +30.43% | +108.45% | 4.65TCr | |
| +2.58% | +4.31% | +32.49% | +39.59% | 4.48TCr | |
| +4.09% | +4.62% | +228.06% | +845.00% | 4.16TCr | |
| -0.47% | +9.60% | +27.53% | +52.88% | 3.53TCr | |
| +3.80% | -6.42% | +98.16% | +68.09% | 3.33TCr | |
| +1.48% | +3.13% | -38.80% | +388.84% | 2.51TCr | |
| Average | +2.06% | +3.29% | +53.07% | +194.28% | 5TCr | |
| Weighted average by Cap. | +2.29% | +3.97% | +53.75% | +173.19% |
Employees
6
